Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

61509 1497862462HCLSReviewTaiwanJune2017.pdf
Energy Boardroom

Pfizer concedes Celebrex to Actavis, Teva after 2015 patent strike-down

24.04.2014 / Fierce Pharma

Pfizer has settled its patent fight with Teva Pharmaceutical Industries and Actavis, allowing both generics companies to launch Celebrex copies in December at the latest. That's 6 months after the 2014 patent expiration, but 12 months ahead of the reissued 2015 method patent.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: